InformedDNA and Know Your Lemons Foundation® Expand Access to Early Detection and Genetic Counseling for Breast Cancer
Partnership combines expertise in oncology, patient education and precision medicine with personalized screening recommendations to those at various risks for breast cancer Extends Know Your Lemons’ mission to provide breast cancer education and guidance St. Petersburg, FL and Lewisville, ID – October 15, 2025 – InformedDNA®, a precision health company revolutionizing the application of genomic […]
InformedDNA in Healthcare Business Today
We are pleased to announce our feature in Healthcare Business Today, where CEO Dr. Surya Singh discusses InformedDNA’s strategic focus on the applied use of genomics to drive a more personalized and preventive future for population health. READ MORE
Quest Diagnostics Launches Advanced Pharmacogenomics (PGx) Offering
InformedDNA is thrilled to announce our new partnership with Quest. This collaboration is a significant step forward in personalized medicine. It combines Quest’s diagnostic expertise with InformedDNA’s advanced clinical decision support. This helps healthcare providers move beyond trial-and-error prescribing, and to use genetic insights to guide decisions, reduce the risk of adverse drug reactions, and ultimately improve patient outcomes”
Podcast Alert! Outcomes Rocket episode with Dr. Surya Singh, CEO of InformedDNA.
Tune in to hear InformedDNA’s CEO discuss how we pair technology and genetic information to enhance population health. Listen Now!
The Cancer Letter: Genetic counseling can improve genetic screening and accelerate clinical trial success
This article highlights how genetic counseling can benefit clinical trials. Ashley Cannon, InformedDNA’s Clinical Program Manager, explains how the advanced training of genetic counselors can aid in the clinical trial process while also building trust and engagement among patients. Click here to read the full article.
InformedDNA Acquires Coriell Life Sciences, Expanding Precision Health Capabilities
Precision health leader adds Coriell’s pharmacogenomics capabilities to expand the application of genomics and increase patient access to more personalized and effective health care St. Petersburg, FL – March 19, 2025 – InformedDNA®, a precision health company revolutionizing the application of genomic insights, today announced the acquisition of Coriell Life Sciences, a provider of pharmacogenomic services […]
The Cancer Letter: NCCN publishes patient resource on genetic testing to guide patient decisionmaking
The National Comprehensive Cancer Network published its first patient resource aimed at informing people about the latest recommendations around hereditary and familial cancer risk. Eleanor Riggs, manager of clinical content at InformedDNA, spoke with The Cancer Letter about the value of the new guide and the growing role of genetics in oncology treatments.
ALM Benefits Pro: Will Wegovy help that worker lose weight?
New tests may show how much value a particular obese patient will get for a GLP-1 agonist prescription dollar. Two health technology startups have an idea for treating obesity: Use genetic tests and other tests to see whether expensive weight-loss drugs will help obese people much before giving them the…
Press Release: Phenomix Sciences and InformedDNA Partner to Advance Genetics-Driven Obesity Care
Launching at HLTH 2024, the groundbreaking partnership offers payers, health systems, employers, and life science organizations access to personalized obesity care and treatment planning based on a patient’s DNA…
The Cancer Letter: Joint byline, ‘Is gastrectomy indicated?’
A study recently published in JAMA sheds light on cancer risks associated with carrying germline CDH1 mutations, challenging previous, potentially inflated, lifetime cancer risk estimates. InformedDNA, FORCE: Facing Our Risk of Cancer Empowered, and No Stomach For Cancer, collaborate as patient advocates, educators, and experts to support individuals and families impacted by gastric cancer to help them navigate this complex genetic landscape. Subscribers to The Cancer Letter can login to read the full article.
